Abstract
BackgroundAlthough cognitive behavioral therapy (CBT) is considered a promising adjuvant to pharmacotherapy for treating bipolar disorder (BD), its efficacy is unproven. The present review and meta-analysis evaluated the treatment outcomes of patients with BD treated with CBT plus medication and compared these data with the outcomes of those who received standard care alone.MethodsElectronic searches from inception to July 31, 2016, were performed using PubMed, Medline OVID, Cochrane Library, EMBASE, CINAHL plus, and PsycINFO. In the extensive electronic literature search, keywords such as “bipolar disorder,” “manic-depressive psychosis,” “bipolar affective disorder,” “bipolar depression,” “cognitive therapy,” “cognitive-behavioral therapy,” and “psychotherapy” were transformed into MeSH terms, and only randomized controlled trials (RCTs) were included. The pooled odds ratios (ORs) of relapse rates and Hedges’s g, along with 95% confidence intervals (CIs), for the mean differences in the levels of depression, mania, and psychosocial functioning were calculated. Further subgroup analyses were conducted according to the characteristics of the CBT approaches, patients, and therapists, if the data were available.ResultA total of 19 RCTs comprising 1384 patients with type I or II BD were enrolled in our systematic review and meta-analysis. The main analysis revealed that CBT could lower the relapse rate (pooled OR = 0.506; 95% CI = 0.278 −0.921) and improve depressive symptoms (g = −0.494; 95% CI = −0.963 to −0.026), mania severity (g = −0.581; 95% CI = −1.127 to −0.035), and psychosocial functioning (g = 0.457; 95% CI = 0.106–0.809).ConclusionsCBT is effective in decreasing the relapse rate and improving depressive symptoms, mania severity, and psychosocial functioning, with a mild-to-moderate effect size. Subgroup analyses indicated that improvements in depression or mania are more potent with a CBT treatment duration of ≥90 min per session, and the relapse rate is much lower among patients with type I BD.
Highlights
Bipolar disorder (BD) is a severe mental disease with a lifelong course and considerable morbidity and mortality
Subgroup analyses indicated that improvements in depression or mania are more potent with a cognitive behavioral therapy (CBT) treatment duration of !90 min per session, and the relapse rate is much lower among patients with type I bipolar disorder (BD)
Through independent reviews based on the inclusion/exclusion criteria, 19 randomized controlled trials (RCTs) evaluating the efficacy of CBT for patients with BD were included in this meta-analysis [25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43]; these studies comprised a total of 716 patients with CBT and 668 controls
Summary
Bipolar disorder (BD) is a severe mental disease with a lifelong course and considerable morbidity and mortality. BD has a lifelong prevalence rate of 1%–1.5% and is characterized by recurrent episodes of mania, depression, or a mixture of both phases [1]. The inter-personal relationships of patients with BD are highly affected by the dramatic alternation of manic/hypomanic and depressive mood cycles. In the United States, the direct and indirect costs of BD were estimated to be USD 151 billion in 2009 [7]. Millions of patients worldwide are affected by this severe mood illness, incurring costs of billions of USD for the years lived with disability [8]. Cognitive behavioral therapy (CBT) is considered a promising adjuvant to pharmacotherapy for treating bipolar disorder (BD), its efficacy is unproven. The present review and meta-analysis evaluated the treatment outcomes of patients with BD treated with CBT plus medication and compared these data with the outcomes of those who received standard care alone
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
